Biogen Alzheimer’s disease drug results impress, but more research still needed
July 26, 2018 at 07:52 AM EDT
Company shares have surged on investor hopes for the drug, but experts remain cautious.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.